Joseph A. Reddy

3.4k total citations · 1 hit paper
49 papers, 2.9k citations indexed

About

Joseph A. Reddy is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Joseph A. Reddy has authored 49 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 22 papers in Oncology and 12 papers in Rheumatology. Recurrent topics in Joseph A. Reddy's work include Folate and B Vitamins Research (12 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and RNA Interference and Gene Delivery (7 papers). Joseph A. Reddy is often cited by papers focused on Folate and B Vitamins Research (12 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and RNA Interference and Gene Delivery (7 papers). Joseph A. Reddy collaborates with scholars based in United States, Switzerland and Israel. Joseph A. Reddy's co-authors include Christopher P. Leamon, Philip S. Low, Marilynn Vetzel, Iontcho R. Vlahov, Yehuda G. Assaraf, Elaine Westrick, Nikki Parker, Le-Cun Xu, Ryan Dorton and Mary Jo Turk and has published in prestigious journals such as Blood, Cancer Research and Scientific Reports.

In The Last Decade

Joseph A. Reddy

49 papers receiving 2.8k citations

Hit Papers

The folate receptor as a rational therapeutic target for ... 2014 2026 2018 2022 2014 100 200 300

Peers

Joseph A. Reddy
Elaine Westrick United States
Iontcho R. Vlahov United States
Mary Jo Turk United States
Nikki Parker United States
Young Mo Kang South Korea
Sumith A. Kularatne United States
Galia Blum Israel
Ruiwu Liu United States
Vuong Trieu United States
Elaine Westrick United States
Joseph A. Reddy
Citations per year, relative to Joseph A. Reddy Joseph A. Reddy (= 1×) peers Elaine Westrick

Countries citing papers authored by Joseph A. Reddy

Since Specialization
Citations

This map shows the geographic impact of Joseph A. Reddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph A. Reddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph A. Reddy more than expected).

Fields of papers citing papers by Joseph A. Reddy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph A. Reddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph A. Reddy. The network helps show where Joseph A. Reddy may publish in the future.

Co-authorship network of co-authors of Joseph A. Reddy

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph A. Reddy. A scholar is included among the top collaborators of Joseph A. Reddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph A. Reddy. Joseph A. Reddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reddy, Joseph A., Melissa Nelson, Marilynn Vetzel, et al.. (2020). Pre-clinical studies of EC2629, a highly potent folate- receptor-targeted DNA crosslinking agent. Scientific Reports. 10(1). 12772–12772. 8 indexed citations
2.
Chu, Haiyan, Jonathan M. Shillingford, Joseph A. Reddy, et al.. (2019). Detecting Functional and Accessible Folate Receptor Expression in Cancer and Polycystic Kidneys. Molecular Pharmaceutics. 16(9). 3985–3995. 6 indexed citations
3.
Reddy, Joseph A., Ryan Dorton, Melissa Nelson, et al.. (2018). Pre-clinical evaluation of EC1456, a folate-tubulysin anti-cancer therapeutic. Scientific Reports. 8(1). 8943–8943. 33 indexed citations
4.
Leamon, Christopher P., Joseph A. Reddy, Iontcho R. Vlahov, et al.. (2017). Enhancing the therapeutic range of a targeted small-molecule tubulysin conjugate for folate receptor-based cancer therapy. Cancer Chemotherapy and Pharmacology. 79(6). 1151–1160. 10 indexed citations
5.
Guertin, Amy D., Jennifer O’Neil, Alexander Stoeck, et al.. (2016). High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide. Molecular Cancer Therapeutics. 15(8). 1998–2008. 16 indexed citations
6.
Nelson, Melissa, et al.. (2016). Development and validation of a UPLC–MS/MS method for the novel folate-targeted small molecule drug conjugate EC1456 and its metabolites in tumor homogenates from mice. Journal of Pharmaceutical and Biomedical Analysis. 122. 148–156. 4 indexed citations
7.
Assaraf, Yehuda G., Christopher P. Leamon, & Joseph A. Reddy. (2014). The folate receptor as a rational therapeutic target for personalized cancer treatment. Drug Resistance Updates. 17(4-6). 89–95. 329 indexed citations breakdown →
8.
Vlahov, Iontcho R., Yu Wang, Marilynn Vetzel, et al.. (2011). Acid mediated formation of an N-acyliminium ion from tubulysins: A new methodology for the synthesis of natural tubulysins and their analogs. Bioorganic & Medicinal Chemistry Letters. 21(22). 6778–6781. 16 indexed citations
9.
Leamon, Christopher P., Joseph A. Reddy, Patrick Klein, et al.. (2010). Reducing Undesirable Hepatic Clearance of a Tumor-Targeted Vinca Alkaloid via Novel Saccharopeptidic Modifications. Journal of Pharmacology and Experimental Therapeutics. 336(2). 336–343. 41 indexed citations
10.
Leamon, Christopher P., et al.. (2008). Impact of High and Low Folate Diets on Tissue Folate Receptor Levels and Antitumor Responses Toward Folate-Drug Conjugates. Journal of Pharmacology and Experimental Therapeutics. 327(3). 918–925. 56 indexed citations
11.
Leamon, Christopher P., Joseph A. Reddy, Iontcho R. Vlahov, et al.. (2007). Comparative preclinical activity of the folate‐targeted Vinca alkaloid conjugates EC140 and EC145. International Journal of Cancer. 121(7). 1585–1592. 70 indexed citations
12.
Reddy, Joseph A., Hari Krishna R. Santhapuram, Elaine Westrick, et al.. (2006). Folate receptor targeted anti-tumor activity of EC-0225, a folate-targeted dual drug conjugate. Cancer Research. 66. 135–135. 1 indexed citations
13.
Reddy, Joseph A., Elaine Westrick, Iontcho R. Vlahov, et al.. (2005). Folate receptor specific anti-tumor activity of folate–mitomycin conjugates. Cancer Chemotherapy and Pharmacology. 58(2). 229–236. 62 indexed citations
14.
Paulos, Chrystal M., Joseph A. Reddy, Christopher P. Leamon, Mary Jo Turk, & Philip S. Low. (2004). Ligand Binding and Kinetics of Folate Receptor Recycling in Vivo: Impact on Receptor-Mediated Drug Delivery. Molecular Pharmacology. 66(6). 1406–1414. 189 indexed citations
15.
Turk, Mary Jo, Joseph A. Reddy, Jean Chmielewski, & Philip S. Low. (2002). Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1559(1). 56–68. 95 indexed citations
16.
Reddy, Joseph A., et al.. (2002). Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors. Gene Therapy. 9(22). 1542–1550. 134 indexed citations
17.
Hofland, Hans, Christophe Masson, Joseph A. Reddy, et al.. (2002). Folate-Targeted Gene Transfer in Vivo. Molecular Therapy. 5(6). 739–744. 78 indexed citations
18.
Reddy, Joseph A., D. Wade Clapp, & Philip S. Low. (2001). Retargeting of viral vectors to the folate receptor endocytic pathway. Journal of Controlled Release. 74(1-3). 77–82. 17 indexed citations
19.
Reddy, Joseph A. & Philip S. Low. (2000). Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. Journal of Controlled Release. 64(1-3). 27–37. 132 indexed citations
20.
Reddy, Joseph A., Laura S. Haneline, Edward F. Srour, et al.. (1999). Expression and Functional Characterization of the β-Isoform of the Folate Receptor on CD34+ Cells. Blood. 93(11). 3940–3948. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026